Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 2733 to 2782 of 6456 in total
Value Type: Ranked
Interaction Map: High confidence
Filtered: 1
\def\wcA{0.14285714285714\textwidth} \def\wcB{0.14285714285714\textwidth} \def\wcC{0.14285714285714\textwidth} \def\wcD{0.14285714285714\textwidth} \def\wcE{0.14285714285714\textwidth} \def\wcF{0.14285714285714\textwidth} \begin{longtable}{|c|c|c|c|c|c|} \hline \parbox{\wcA}{\vspace{3pt}\noindent Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent network\_comparison\vspace{3pt}}\\ \hline \hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1367\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent cytoskeleton related vitamin a responsive protein; glutamate transporter eeac1-associated protein; dermal papilla derived protein 11; putative mapk activating protein pm27. [source:refseq;acc:nm\_006407]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 199.771\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 204.287\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 4.516\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent neuronal calcium sensor 1 (ncs-1) (frequenin homolog) (frequenin-like protein) (frequenin-like ubiquitous protein). [source:swissprot;acc:p36610]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 223.887\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 228.799\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02194\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1368\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent epididymal secretory protein e1 precursor (niemann-pick disease type c2 protein) (epi-1) (he1) (epididymal secretory protein 14.6) (esp14.6). [source:swissprot;acc:q15668]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 205.204\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 200.71\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 4.494\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent polyamine oxidase isoform 1; polyamine oxidase; flavin-containing spermine oxidase; putative cyclin g1 interacting protein; flavin containing amine oxidase. [source:refseq;acc:nm\_019025]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 228.644\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 223.736\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02194\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1369\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent cysteine-rich protein 1 (cysteine-rich intestinal protein) (crip) (cysteine-rich heart protein) (hcrhp). [source:swissprot;acc:p50238]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 221.152\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 216.659\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 4.493\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent cytochrome c-type heme lyase (ec 4.4.1.17) (cchl) (holocytochrome c- type synthase). [source:swissprot;acc:p53701]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 228.644\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 223.736\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02194\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1370\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent cleavage and polyadenylation specific factor 4, 30kd subunit; cleavage-polyadenylation specificity factor, 30kd; no arches-like (zebrafish) zinc finger protein; cleavage-polyadenylation specificity factor. [source:refseq;acc:nm\_006693]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 107.842\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 112.329\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 4.487\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent cytoplasmic protein nck1 (nck adaptor protein 1) (sh2/sh3 adaptor protein nck-alpha). [source:swissprot;acc:p16333]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 205.185\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 200.784\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02192\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1371\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent glutathione s-transferase theta 1 (ec 2.5.1.18) (gst class-theta) (glutathione transferase t1-1). [source:swissprot;acc:p30711]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 228.646\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 223.744\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02191\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent trs85 homolog. [source:swissprot;acc:q9y2l5]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 107.842\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 112.329\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 4.487\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1372\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent a-raf proto-oncogene serine/threonine-protein kinase (ec 2.7.1.-) (a-raf-1) (proto-oncogene pks). [source:swissprot;acc:p10398]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 129.913\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 134.399\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 4.486\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent suppressor of cytokine signaling 1 (socs-1) (jak-binding protein) (jab) (stat induced stat inhibitor 1) (ssi-1) (tec-interacting protein 3) (tip-3). [source:swissprot;acc:o15524]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 216.542\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 211.908\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.02187\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1373\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent glia maturation factor gamma (gmf-gamma). [source:swissprot;acc:o60234]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent raf proto-oncogene serine/threonine-protein kinase (ec 2.7.1.-) (raf-1) (c-raf). [source:swissprot;acc:p04049]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 129.921\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 134.406\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 4.485\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1374\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent asc-1 complex subunit p100. [source:refseq;acc:nm\_032204]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 216.542\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 211.908\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02187\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent wd-repeat protein wdc146. [source:swissprot;acc:q9c0j8]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 108.289\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 112.772\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 4.483\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1375\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent cleavage and polyadenylation specificity factor, 160 kda subunit (cpsf 160 kda subunit). [source:swissprot;acc:q10570]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent fk506-binding protein 1a (ec 5.2.1.8) (peptidyl-prolyl cis-trans isomerase) (ppiase) (rotamase) (12 kda fkbp) (fkbp-12) (immunophilin fkbp12). [source:swissprot;acc:p20071]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 216.542\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 211.908\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02187\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1376\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent eyes absent homolog 3. [source:swissprot;acc:q99504]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 218.537\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 213.91\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02163\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent uv excision repair protein rad23 homolog a (hhr23a). [source:swissprot;acc:p54725]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 220.987\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 225.468\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 4.481\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1377\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent 26s proteasome non-atpase regulatory subunit 4 (26s proteasome regulatory subunit s5a) (rpn10) (multiubiquitin chain binding protein) (antisecretory factor-1) (af) (asf). [source:swissprot;acc:p55036]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent sal-like protein 2 (zinc finger protein sall2) (hsal2). [source:swissprot;acc:q9y467]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 218.471\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 213.876\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02148\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1378\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent inositol polyphosphate 5-phosphatase ocrl-1 (ec 3.1.3.36) (lowe's oculocerebrorenal syndrome protein). [source:swissprot;acc:q01968]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 220.987\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 225.468\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 4.481\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent sal-like protein 3 (zinc finger protein sall3) (hsall3). [source:swissprot;acc:q9bxa9]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 218.47\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent 213.876\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.02148\vspace{3pt}}}\\\cline{1-2}\cline{5-5} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1379\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent arginine-glutamic acid dipeptide (re) repeats; atrophin 1-like; arginine glutamic acid dipeptide re repeats. [source:refseq;acc:nm\_012102]\vspace{3pt}}&&&\parbox{\wcE}{\vspace{3pt}\noindent 213.875\vspace{3pt}}&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent uv excision repair protein rad23 homolog b (hhr23b) (xp-c repair complementing complex 58 kda protein) (p58). [source:swissprot;acc:p54727]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 220.987\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 225.468\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 4.481\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1380\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent myosin vi. [source:swissprot;acc:q9um54]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent ubiquitin carboxyl-terminal hydrolase 8 (ec 3.1.2.15) (ubiquitin thiolesterase 8) (ubiquitin-specific processing protease 8) (deubiquitinating enzyme 8). [source:swissprot;acc:p40818]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 218.47\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 213.876\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02148\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1381\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent maguk p55 subfamily member 2 (mpp2 protein) (discs, large homolog 2). [source:swissprot;acc:q14168]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 228.513\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 232.983\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 4.47\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent rod1 regulator of differentiation 1; fission yeast differentiation regulator; regulator of differentiation (in s. pombi) 1; regulator of differentiation (in s. pombe) 1. [source:refseq;acc:nm\_005156]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 218.47\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 213.876\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.02148\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1382\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent polypyrimidine tract binding protein 2; neural polypyrimidine tract binding protein; ptb-like protein. [source:refseq;acc:nm\_021190]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent serine/threonine protein phosphatase 2a, 56 kda regulatory subunit, epsilon isoform (pp2a, b subunit, b' epsilon isoform) (pp2a, b subunit, b56 epsilon isoform) (pp2a, b subunit, pr61 epsilon isoform) (pp2a, b subunit, r5 epsilon isoform). [source:swissprot;acc:q16537]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 130.066\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 134.527\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 4.461\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1383\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent adaptor-associated kinase 1. [source:refseq;acc:nm\_014911]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 218.47\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 213.876\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02148\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent cyclin g2. [source:swissprot;acc:q16589]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 130.066\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 134.527\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 4.461\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1384\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent atrophin-1 (dentatorubral-pallidoluysian atrophy protein). [source:swissprot;acc:p54259]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 218.471\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 213.876\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02148\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent cyclin g1 (cyclin g). [source:swissprot;acc:p51959]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 130.066\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 134.527\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 4.461\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1385\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent dead (asp-glu-ala-asp) box polypeptide 47; hqp0256 protein. [source:refseq;acc:nm\_016355]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 218.47\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 213.875\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02148\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent serine/threonine protein phosphatase 2a, 56 kda regulatory subunit, alpha isoform (pp2a, b subunit, b' alpha isoform) (pp2a, b subunit, b56 alpha isoform) (pp2a, b subunit, pr61 alpha isoform) (pp2a, b subunit, r5 alpha isoform). [source:swissprot;acc:q15172]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 130.066\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 134.527\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 4.461\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1386\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent rho-gtpase activating protein 10. [source:refseq;acc:nm\_020824]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 218.47\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 213.876\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02148\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent transportin-sr; importin 12. [source:refseq;acc:nm\_012470]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 225.305\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 229.766\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 4.461\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1387\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent my016 protein. [source:sptrembl;acc:q9h3k6]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 224.755\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 229.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 4.445\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent sal-like protein 1 (zinc finger protein sall1) (spalt-like transcription factor 1) (hsal1). [source:swissprot;acc:q9nsc2]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 218.47\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 213.875\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.02148\vspace{3pt}}}\\\cline{1-2}\cline{4-5} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1388\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent sal-like protein 4 (zinc finger protein sall4). [source:swissprot;acc:q9ujq4]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 218.471\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 213.876\vspace{3pt}}&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent sodium/potassium-transporting atpase alpha-1 chain precursor (ec 3.6.3.9) (sodium pump 1) (na+/k+ atpase 1). [source:swissprot;acc:p05023]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 214.717\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 219.157\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 4.44\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1389\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent 2-oxoisovalerate dehydrogenase beta subunit, mitochondrial precursor (ec 1.2.4.4) (branched-chain alpha-keto acid dehydrogenase e1 component beta chain) (bckdh e1-beta). [source:swissprot;acc:p21953]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 218.47\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 213.875\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02148\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent cathepsin l2 precursor (ec 3.4.22.43) (cathepsin v) (cathepsin u). [source:swissprot;acc:o60911]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 214.717\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 219.157\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 4.44\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1390\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent cathepsin l precursor (ec 3.4.22.15) (major excreted protein) (mep). [source:swissprot;acc:p07711]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent ccr4-not transcription complex, subunit 4; not4 (negative regulator of transcription 4, yeast) homolog; ccr4-not transcription complex, subunit. [source:refseq;acc:nm\_013316]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 218.47\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 213.875\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.02148\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1391\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent phosphatidylinositol-binding clathrin assembly protein (clathrin assembly lymphoid myeloid leukemia protein). [source:swissprot;acc:q13492]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent sodium/potassium-transporting atpase alpha-3 chain (ec 3.6.3.9) (sodium pump 3) (na+/k+ atpase 3) (alpha(iii)). [source:swissprot;acc:p13637]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 214.717\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 219.157\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 4.44\vspace{3pt}}\\\hline nd{longtable}
Legend:
- Rank is the rank after comparing the two networks
- Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
- Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
- Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
- Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
- Filtered specifies whether we only included the high confidence microarry measurements or not.

- http://analysis.yellowcouch.org/